L-Carnitine

L-Carnitine (levocarnitine) is a naturally occurring amino acid derivative essential for transporting long-chain fatty acids into mitochondria for energy production via beta-oxidation. Synthesized endogenously from lysine and methionine, it plays critical roles in energy metabolism, particularly in high-energy tissues like heart, brain, and skeletal muscle. FDA approved as Carnitor® for treating primary and secondary carnitine deficiency. Various forms exist including Acetyl-L-Carnitine (ALCAR) for cognitive support, L-Carnitine L-Tartrate (LCLT) for exercise recovery, and Propionyl-L-Carnitine for cardiovascular health. Extensively studied with over 200 clinical trials examining effects on weight management, exercise performance, heart health, cognitive function, and male fertility.

• Fat Metabolism & Weight Loss
• Mitochondrial Energy Support
• Heart Health

Maximum bioavailability (100% vs 14-18% oral), rapid onset of action, bypasses gut microbiome conversion to TMAO, particularly useful for carnitine deficiency states and clinical settings.

Injectable L-Carnitine delivers the compound directly to circulation, bypassing the limitations of intestinal absorption. This provides immediate availability for fatty acid transport into mitochondria. IV/IM routes are preferred in clinical settings for carnitine deficiency and dialysis patients.

Peak plasma concentration: 3.5 hrs. Elimination half-life: 17 hrs. Largely cleared by: ~3.5 days.

Research protocols from published literature — not dosing recommendations.

• NAD+ — Synergistic: Both support mitochondrial function and energy metabolism through complementary pathways - L-Carnitine enhances fatty acid transport while NAD+ supports electron transport chain
• Coenzyme Q10 — Synergistic: CoQ10 and L-Carnitine work synergistically in mitochondrial energy production - combination shows enhanced benefits for heart health and exercise performance in studies
• Alpha Lipoic Acid — Synergistic: Both compounds support mitochondrial function and have antioxidant properties - often combined in longevity and metabolic support protocols
• Omega-3 Fatty Acids — Synergistic: L-Carnitine transports fatty acids including omega-3s into mitochondria - research suggests combination may increase CPT-I activity and improve energy metabolism
• Thyroid Hormones — Use Caution: L-Carnitine may inhibit thyroid hormone activity by preventing T3 and T4 from entering cell nuclei - those with hypothyroidism should consult healthcare provider before use
• Warfarin — Monitor Combination: Some case reports suggest L-Carnitine may enhance warfarin's anticoagulant effect - monitor INR closely if combining
• Acenocoumarol — Monitor Combination: May potentiate anticoagulant effects similar to warfarin - requires monitoring of coagulation parameters
• BPC-157 — Compatible: No known interactions - different mechanisms with L-Carnitine supporting energy metabolism and BPC-157 supporting tissue repair

Supplies:

• Sterile L-Carnitine solution (pre-made)
• Sterile syringes (3-5mL for IM)
• Alcohol swabs
• Normal saline (for IV dilution if needed)
• Sterile needles (22-25 gauge for IM)

1. 1L-Carnitine injectable typically comes pre-mixed as a sterile solution
2. 2Check solution clarity - should be clear and colorless
3. 3For IV: May be diluted in normal saline for infusion
4. 4For IM: Draw appropriate volume directly from vial
5. 5Clean injection site thoroughly with alcohol
6. 6Administer slowly - IV bolus over 2-3 minutes minimum

Immediate: 100% bioavailability and rapid tissue distribution. Days 1-7: Normalized carnitine levels, potential energy improvements. Weeks 2-4: Enhanced fat utilization during exercise, improved recovery. Weeks 4-8: Sustained metabolic benefits, potential body composition changes. Side effects: Injection site reactions (mild), fishy body odor at high doses.

FDA-approved for specific indications - well-established safety profile. May cause injection site discomfort or temporary warmth. High doses can cause fishy body odor due to TMA production. Use caution in hypothyroidism - may inhibit thyroid hormone action. Monitor if on anticoagulants (warfarin) - may enhance effect. Renal patients should be monitored for TMA/TMAO accumulation.

FDA-approved for specific indications - well-established safety profile. May cause injection site discomfort or temporary warmth. High doses can cause fishy body odor due to TMA production. Use caution in hypothyroidism - may inhibit thyroid hormone action. Monitor if on anticoagulants (warfarin) - may enhance effect. Renal patients should be monitored for TMA/TMAO accumulation.

L-Carnitine should be stored at Room temperature unopened; refrigerate after opening.